Works matching IS 15257304 AND DT 2017 AND VI 18 AND IP 1

Results: 28
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17

    Treatment Rationale and Design for J-AXEL: A Randomized Phase 3 Study Comparing Nab-Paclitaxel With Docetaxel in Patients With Previously Treated Advanced Non—Small-Cell Lung Cancer.

    Published in:
    Clinical Lung Cancer, 2017, v. 18, n. 1, p. 100, doi. 10.1016/j.cllc.2016.08.003
    By:
    • Yasuto Yoneshima;
    • Satoshi Morita;
    • Masahiko Ando;
    • Satoru Miura;
    • Hiroshige Yoshioka;
    • Tetsuya Abe;
    • Terufumi Kato;
    • Masashi Kondo;
    • Yukio Hosomi;
    • Katsuyuki Hotta;
    • Nobuyuki Yamamoto;
    • Junji Kishimoto;
    • Yoichi Nakanishi;
    • Isamu Okamoto
    Publication type:
    Article
    18
    19
    20
    21
    22

    Treatment Rationale and Study Design for the RELAY Study: A Multicenter, Randomized, Double-Blind Study of Erlotinib With Ramucirumab or Placebo in Patients With Epidermal Growth Factor Receptor Mutation- Positive Metastatic Non—Small-Cell Lung Cancer.

    Published in:
    2017
    By:
    • Garon, Edward B.;
    • Reck, Martin;
    • Paz-Ares, Luis;
    • Ponce, Santiago;
    • Jaime, Jesus Corral;
    • Juan, Oscar;
    • Nadal, Ernest;
    • Lee, Pablo;
    • Dalai, Rita;
    • Jingyi Liu;
    • Shuang He;
    • Treat, Joseph;
    • Kazuhiko Nakagawa;
    • Dalal, Rita;
    • Liu, Jingyi;
    • He, Shuang;
    • Nakagawa, Kazuhiko
    Publication type:
    journal article
    23
    24
    25

    Randomized Phase 2 Trial of Pharmacodynamic Separation of Pemetrexed and Intercalated Erlotinib Versus Pemetrexed Alone for Advanced Nonsquamous, Non—small-cell Lung Cancer.

    Published in:
    Clinical Lung Cancer, 2017, v. 18, n. 1, p. 60, doi. 10.1016/j.cllc.2016.10.003
    By:
    • Tianhong Li;
    • Piperdi, Bilal;
    • Walsh, William V.;
    • Mimi Kim;
    • Beckett, Laurel A.;
    • Gucalp, Rasim;
    • Haigentz Jr., Missak;
    • Bathini, Venu G.;
    • Huiyu Wen;
    • Kaili Zhou;
    • Pasquinelli, Patricia B.;
    • Gajavelli, Srikanth;
    • Sreedhara, Meera;
    • Xianhong Xie;
    • Lara Jr., Primo N.;
    • Gandara, David R.;
    • Perez-Soler, Roman
    Publication type:
    Article
    26

    Efficacy and Safety of Onartuzumab in Combination With First-Line Bevacizumab- or Pemetrexed-Based Chemotherapy Regimens in Advanced Non-Squamous Non-Small-Cell Lung Cancer.

    Published in:
    2017
    By:
    • Wakelee, Heather;
    • Zvirbule, Zanete;
    • De Braud, Filippo;
    • Kingsley, C. Daniel;
    • Mekhail, Tarek;
    • Lowe, Thomas;
    • Schiitte, Wolfgang;
    • Lena, Herve;
    • Lawler, William;
    • Braiteh, Fadi;
    • Cosgriff, Thomas;
    • Kaen, Diego;
    • Boyer, Michelle;
    • Jessie Hsu;
    • Phan, See;
    • Novello, Silvia;
    • Schütte, Wolfgang;
    • Lena, Hervé;
    • Hsu, Jessie
    Publication type:
    journal article
    27
    28

    Phase 2 Study of Erlotinib in Combination With Linsitinib (OSI-906) or Placebo in Chemotherapy-Naive Patients With Non-Small-Cell Lung Cancer and Activating Epidermal Growth Factor Receptor Mutations.

    Published in:
    2017
    By:
    • Leighl, Natasha B.;
    • Rizvi, Naiyer A.;
    • de Lima Jr., Lopes Gilberto;
    • Arpornwirat, Wichit;
    • Rudin, Charles M.;
    • Chiappori, Alberto A.;
    • Myung-Ju Ahn;
    • Chow, Laura Q. M.;
    • Bazhenova, Lyudmila;
    • Dechaphunkul, Arunee;
    • Sunpaweravong, Patrapim;
    • Eaton, Keith;
    • Jihong Chen;
    • Medley, Sonja;
    • Poondru, Srinivasu;
    • Singh, Margaret;
    • Steinberg, Joyce;
    • Juergens, Rosalyn A.;
    • Gadgeel, Shirish M.;
    • de Lima, Lopes Gilberto Jr
    Publication type:
    journal article